FINWIRES · TerminalLIVE
FINWIRES

Alpha Tau Medical, Tolmar International Agree to Develop, Commercialize Prostate Cancer Therapy

By

Alpha Tau Medical (DRTS) and Tolmar International have agreed to develop and commercialize Alpha DaRT therapy for the treatment of prostate cancer in the US, the companies said Wednesday.

Under the agreement, Alpha Tau will lead clinical development and manufacture the therapy, while Tolmar International will receive exclusive rights it in the US, according to the companies.

Additionally, the companies said Tolmar International will make a $20 million equity investment in Alpha Tau at $11.99 per share and provide $15 million towards a new US manufacturing facility.

The deal also includes up to $96.5 million in development and regulatory milestones and up to $65 million in commercial milestone payments for the initial indication, Alpha Tau Medical and Tolmar International said.

Alpha Tau said it will sell Alpha DaRT to Tolmar at 60% of onward net sales price, subject to certain adjustments.

Alpha Tau Medical shares were over 15% higher in early Wednesday trading.

Price: $10.31, Change: $+1.38, Percent Change: +15.45%

Related Articles

Wire

Update: Nova Minerals Says New South Wales Court Approves New US Holding Entity Plan; Shares Fall 6%

(Updates to add stock movement in the headline and last paragraph)Nova Minerals (ASX:NVA) said the Supreme Court of New South Wales has approved its proposed schemes of arrangement, enabling newly formed Nova Minerals Corp to acquire all existing shares and Nasdaq-listed warrants and become the group's new US-based holding entity, according to an Australian bourse filing on Tuesday after market hours.The schemes are expected to take legal effect on Wednesday upon lodgment of the court orders with the Australian Securities and Investments Commission, after which the company shares are anticipated to be suspended from trading on the Australian Securities Exchange, the filing added.The company's shares fell around 6% in recent Wednesday trade.

ASX:NVA
Wire

Netskope Joins Anthropic's Project Glasswing to Spot Code Vulnerabilities

Netskope (NTSK) said late Tuesday it has joined Project Glasswing, an Anthropic initiative that uses the company's most advanced AI model, Mythos Preview, to identify vulnerabilities in software code at greater speed and scale.Netskope has access to Anthropic's Claude Mythos Preview and will share findings with the broader Glasswing coalition and the cybersecurity community as part of the effort.Netskope shares rose 3.1% in after-hours trading.

$NTSK
Wire

TETRA Technologies Launches $100 Million Common Stock Offering

TETRA Technologies (TTI) said Tuesday it commenced an underwritten public offering of $100 million of shares of common stock.The company said it expects to grant underwriters a 30-day option to buy up to an additional $15 million of shares to cover over-allotments.Proceeds will be used for general corporate purposes, including funding construction of its Arkansas bromine project, according to a statement.Shares of the company were down over 9% in extended trading.

$TTI